The clinical presentation—normal hearing, abnormal head impulse test, unidirectional nystagmus, and absence of brainstem signs—confirms peripheral vestibular neuritis (typically HSV-1 reactivation in Scarpa's ganglion). The anchor finding marked A (normal audiogram with abnormal head impulse and unidirectional nystagmus) is the diagnostic hallmark distinguishing vestibular neuritis from labyrinthitis (which includes SNHL) and central causes. Management requires a two-phase approach: (1) SHORT-TERM vestibular suppressants (promethazine, benzodiazepines, metoclopramide) for only 24–72 hours to control intractable nausea and vertigo, and (2) EARLY MOBILIZATION and vestibular rehabilitation exercises (Cawthorne-Cooksey) to accelerate central compensation. Prolonged suppressant use impairs the brain's ability to recalibrate vestibular signals, delaying recovery (Dhingra ENT 7e; Strupp NEJM 2004).
Dhingra ENT 7e Ch 20; Strupp Vestibular neuritis NEJM 2004
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →